Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat neovascular age-related macular degeneration (nAMD) dubbed HG202, developed…
Continue Reading
What You Should Know:
– Trinity Guardion, a leader in hospital bed hygiene solutions, has successfully raised $6 million, including $3.5 million in a Series B funding round.
– This investment will accelerate the production and commercialization of…
Continue Reading
What You Should Know:
– Abbott announced that its FreeStyle Libre 2 and 3 continuous glucose monitoring (CGM) systems have received FDA clearance for use during common imaging procedures, including X-rays, CT scans, and MRIs.
–…
Continue Reading
What You Should Know:
– Innoventric, a leader in transcatheter tricuspid regurgitation (TR) treatment, today announced a $28.5 million Series B funding round to advance its revolutionary cross-caval technology, bringing the total funds raised since inception…
Continue Reading
Los Angeles-based iCardio.ai has received FDA 510(k) clearance for its artificial intelligence software for interpretation of echocardiography, aimed at offering a comprehensive imaging workflow and autonomous preliminary reporting.iCardio.ai develops machine learning and deep learning…
Continue Reading
Happy Health, a health technology company, has received FDA clearance for Happy Ring, a wearable device designed to combine medical accuracy with patient comfort.The ring monitors vital health metrics, including sleep, blood oxygen levels,…
Continue Reading
Introduction
In a significant advancement for personalized medicine, GE HealthCare’s MIM Software has received FDA 510(k) clearance for its Theranostics portfolio. This clearance allows MIM SurePlan MRT to perform absorbed dose calculations using the Monte…
What You Should Know:
– GE HealthCare announced today that its MIM Software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a groundbreaking tool in the fight against Alzheimer’s disease.
–…
Continue Reading
What You Should Know:
– Ascensia Diabetes Care has announced the U.S. launch of the Eversense® 365 continuous glucose monitoring (CGM) system, an advancement in diabetes management.
– Developed by Senseonics Holdings, Inc., Eversense 365 is…
Continue Reading
Sonio, the MedTech company specializing in women’s and children’s health, today announces the official approval by the French Ministry of the Economy and Finance of the acquisition of 100% of shares by Samsung.
The deal…
